These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1834007)

  • 21. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
    Rittmaster RS; Thompson DL
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral arterial and venous concentrations of various androgens in patients with and without hirsutism.
    Chang RJ; Abraham GE
    Obstet Gynecol; 1975 Nov; 46(5):549-50. PubMed ID: 127957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androgens and oligomenorrhea in hirsute women.
    Salman K; Spielvogel RL; Miller JL; Rose LI
    J Am Acad Dermatol; 1991 Mar; 24(3):423-5. PubMed ID: 2061440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of plasma androstenedione to 5 alpha-androstanediol glucuronide in women with idiopathic hirsutism.
    Gompel A; Wright F; Kuttenn F; Mauvais-Jarvis P
    J Clin Endocrinol Metab; 1986 Feb; 62(2):441-4. PubMed ID: 3941165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated production and metabolic clearance rates of androgens in morbidly obese women.
    Samojlik E; Kirschner MA; Silber D; Schneider G; Ertel NH
    J Clin Endocrinol Metab; 1984 Nov; 59(5):949-54. PubMed ID: 6480813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substrate dependency of C19 conjugates in hirsute hyperandrogenic women and the influence of adrenal androgen.
    Carmina E; Gentzschein E; Stanczyk FZ; Lobo RA
    Hum Reprod; 1995 Feb; 10(2):299-303. PubMed ID: 7769052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The correlation between clinical and hormonal parameters in androgenisation.
    Pfeifer M; Prezelj J; Kocijancic A
    Acta Eur Fertil; 1989; 20(1):31-3. PubMed ID: 2528879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of low-dose GnRH analogue (Buserelin) in the treatment of hirsutism.
    Bertoli A; Fusco A; Magnani A; Marini MA; Di Daniele N; Gatti S; Lauro R
    Exp Clin Endocrinol Diabetes; 1995; 103(1):15-20. PubMed ID: 7621099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The determination, secretion and plasma concentration of androgens].
    Stahl F
    Z Gesamte Inn Med; 1979 Oct; 34(20):593-6. PubMed ID: 162017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum androstanediol glucuronide in women with facial hirsutism.
    Salman K; Spielvogel RL; Shulman LH; Miller JL; Vanderlinde RE; Rose LI
    J Am Acad Dermatol; 1992 Mar; 26(3 Pt 2):411-4. PubMed ID: 1564146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The clinical value of 3 alpha-androstanediol-glucuronide in hirsute women].
    Joura EA; Sator MO; Geusau A; Zeisler H; Söregi G; Huber JC
    Wien Klin Wochenschr; 1997 Dec; 109(23):919-21. PubMed ID: 9487606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Should androgen levels be measured in hirsute women with normal menstrual cycles?
    Mehta A; Matwijiw I; Taylor PJ; Salamon EA; Kredentser JV; Faiman C
    Int J Fertil; 1992; 37(6):354-7. PubMed ID: 1360456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.
    Diamanti-Kandarakis E; Kouli CR; Bergiele AT; Filandra FA; Tsianateli TC; Spina GG; Zapanti ED; Bartzis MI
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4006-11. PubMed ID: 10566641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison between urinary 17-ketosteroids and serum androgens in hirsute patients.
    Maroulis GB; Manlimos FS; Abraham GE
    Obstet Gynecol; 1977 Apr; 49(4):454-8. PubMed ID: 140340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endocrinological markers for assessment of hyperandrogenemia in hirsute women.
    Mueller A; Cupisti S; Binder H; Hoffmann I; Kiesewetter F; Beckmann MW; Dittrich R
    Horm Res; 2007; 67(1):35-41. PubMed ID: 17019078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum prostate-specific antigen concentrations are not useful for monitoring the treatment of hirsutism with oral contraceptive pills.
    Escobar-Morreale HF; Avila S; Sancho J
    J Clin Endocrinol Metab; 2000 Jul; 85(7):2488-92. PubMed ID: 10902798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum androgens and depression in women with facial hirsutism.
    Shulman LH; DeRogatis L; Spielvogel R; Miller JL; Rose LI
    J Am Acad Dermatol; 1992 Aug; 27(2 Pt 1):178-81. PubMed ID: 1430353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Steroid hormone levels in serum and skin receptor concentrations in hirsutism.
    Schmidt JB; Huber J; Spona J
    Endocrinol Exp; 1985 Sep; 19(3):147-55. PubMed ID: 2931274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperandrogenism in oligomenorrhoea with minimal or nil 'unwanted hair growth'.
    Bhattacharya SM
    Gynecol Endocrinol; 2009 Jul; 25(7):423-6. PubMed ID: 19499416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoprotein abnormalities in hirsute women. II. Compensatory responses of insulin resistance and dehydroepiandrosterone sulfate with obesity.
    Wild RA; Alaupovic P; Givens JR; Parker IJ
    Am J Obstet Gynecol; 1992 Dec; 167(6):1813-8. PubMed ID: 1471703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.